secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2022-03-08T23:59:59+00:00
Accession:  0000950170-22-003118
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta stockholders approve all proposals at 2022 annual meeting
----------------------------------------------------------------

- Elected Mark Foletta (16,269,503 votes for) and Lesley Russell (16,081,968 votes for) as Class III directors.
- Approved amendment to 2019 Equity Incentive Plan, increasing reserved shares by 1,050,000.
- Advisory say-on-pay proposal passed with 16,369,060 votes for, 933,286 against.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 with 18,378,176 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000095017022003118/0000950170-22-003118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000095017022003118/enta-20220303.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-003118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer